274 related articles for article (PubMed ID: 18310293)
1. Parathyroid tumor development involves deregulation of homeobox genes.
Shen HC; Rosen JE; Yang LM; Savage SA; Burns AL; Mateo CM; Agarwal SK; Chandrasekharappa SC; Spiegel AM; Collins FS; Marx SJ; Libutti SK
Endocr Relat Cancer; 2008 Mar; 15(1):267-75. PubMed ID: 18310293
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors.
Agarwal SK; Jothi R
PLoS One; 2012; 7(5):e37952. PubMed ID: 22666422
[TBL] [Abstract][Full Text] [Related]
3. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia.
Harding B; Lemos MC; Reed AA; Walls GV; Jeyabalan J; Bowl MR; Tateossian H; Sullivan N; Hough T; Fraser WD; Ansorge O; Cheeseman MT; Thakker RV
Endocr Relat Cancer; 2009 Dec; 16(4):1313-27. PubMed ID: 19620250
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene.
Naito J; Kaji H; Sowa H; Kitazawa R; Kitazawa S; Tsukada T; Hendy GN; Sugimoto T; Chihara K
Endocrine; 2006 Jun; 29(3):485-90. PubMed ID: 16943588
[TBL] [Abstract][Full Text] [Related]
6. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
Virchows Arch; 2024 May; 484(5):789-798. PubMed ID: 38244045
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
8. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth.
McKimpson WM; Yuan Z; Zheng M; Crabtree JS; Libutti SK; Kitsis RN
PLoS One; 2015; 10(12):e0145792. PubMed ID: 26709830
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 1.
Agarwal SK
Front Horm Res; 2013; 41():1-15. PubMed ID: 23652667
[TBL] [Abstract][Full Text] [Related]
10. Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas.
Dreijerink KM; Varier RA; van Nuland R; Broekhuizen R; Valk GD; van der Wal JE; Lips CJ; Kummer JA; Timmers HT
Mol Cell Endocrinol; 2009 Dec; 313(1-2):1-8. PubMed ID: 19729047
[TBL] [Abstract][Full Text] [Related]
11. Menin mutations in the diagnosis and prediction of multiple endocrine neoplasia type 1.
Karges W; Ludwig L; Kessler H; Wissmann A; Wagner PK; Boehm BO
Langenbecks Arch Surg; 1998 Apr; 383(2):183-6. PubMed ID: 9641896
[TBL] [Abstract][Full Text] [Related]
12. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
[TBL] [Abstract][Full Text] [Related]
13. The role of menin in parathyroid tumorigenesis.
Davenport C; Agha A
Adv Exp Med Biol; 2009; 668():79-86. PubMed ID: 20175455
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.
Agarwal SK; Kester MB; Debelenko LV; Heppner C; Emmert-Buck MR; Skarulis MC; Doppman JL; Kim YS; Lubensky IA; Zhuang Z; Green JS; Guru SC; Manickam P; Olufemi SE; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
Hum Mol Genet; 1997 Jul; 6(7):1169-75. PubMed ID: 9215689
[TBL] [Abstract][Full Text] [Related]
15. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
Marini F; Brandi ML
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
[TBL] [Abstract][Full Text] [Related]
16. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.
Haven CJ; van Puijenbroek M; Tan MH; Teh BT; Fleuren GJ; van Wezel T; Morreau H
Clin Endocrinol (Oxf); 2007 Sep; 67(3):370-6. PubMed ID: 17555500
[TBL] [Abstract][Full Text] [Related]
17. Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia.
Uchino S; Noguchi S; Nagatomo M; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Wakiya S; Adachi M
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():100s-103s. PubMed ID: 10915003
[TBL] [Abstract][Full Text] [Related]
18. Expression of menin in parathyroid tumors.
Bhuiyan MM; Sato M; Murao K; Imachi H; Namihira H; Takahara J
J Clin Endocrinol Metab; 2000 Jul; 85(7):2615-9. PubMed ID: 10902816
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type 1 (MEN1).
Thakker RV
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):355-70. PubMed ID: 20833329
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
